Argenx to present at 42nd annual j.p. morgan healthcare conference

Amsterdam, the netherlands – argenx (euronext & nasdaq: argx), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that tim van hauwermeiren, chief executive officer, will present at the 42nd annual j.p. morgan healthcare conference on monday, january 8, 2024 at 9:00 a.m. pt.
ARGX Ratings Summary
ARGX Quant Ranking